Table 4 Frequency of falls risk increasing medication use according place of residence
Medication/classification | Long term care (n = 41 residents) N (%) | Retirement home (n = 64 residents) N (%) |
|---|---|---|
Benzodiazepine receptor agonists | 15 (36) | 22 (34) |
Antihypertensive drugs | Â | Â |
 Beta-adrenergic antagonists | 8 (20) | 22 (34) |
 Calcium-channel antagonists | 7 (17) | 14 (22) |
 Diuretics | 10 (24) | 26 (41) |
 Renin–angiotensin–aldosterone system inhibitors | 16 (39) | 23 (36) |
Antidepressants | Â | Â |
 Serotonin reuptake inhibitors | 17 (42) | 22 (34) |
 Trazodone | 8 (20) | 7 (11) |
Tricyclic and other norepinephrine-reuptake Inhibitors | 1 (2) | 4 (6) |
 Serotonin and norepinephrine-reuptake Inhibitors | 2 (5) | 2 (3) |
 Mirtazapine | 3 (7) | 6 (9) |
Antipsychotics* | Â | Â |
 Typical | 0 (0) | 2 (3) |
 Atypical | 19 (46) | 8 (13) |
Narcotics* | 4 (10) | 21 (33) |
Digoxin | 1 (2) | 3 (5) |
Anticholinergic drugs | 6 (14) | 3 (5) |